Bill
Bill > HR3884
US HR3884
US HR3884Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
summary
Introduced
06/07/2023
06/07/2023
In Committee
07/19/2023
07/19/2023
Crossed Over
09/24/2024
09/24/2024
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
AN ACT To amend title XI of the Public Health Service Act to reauthorize the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment.
AI Summary
This bill reauthorizes the program providing for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment under the Public Health Service Act. Specifically, it amends the law to allow for grants and cooperative agreements, in addition to contracts, to be used for this program, and it increases the authorized funding level from $4.455 million per year to $8.205 million per year through fiscal year 2028.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (4)
Last Action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 09/24/2024)
Bill Topics
Health
- ‐ Disease Prevention
- ‐ Research and Development
- ‐ Treatment of Specific Diseases
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/3884/all-info | 06/08/2023 |
| BillText | https://www.congress.gov/118/bills/hr3884/BILLS-118hr3884eh.pdf | 09/25/2024 |
| BillText | https://www.congress.gov/118/bills/hr3884/BILLS-118hr3884rh.pdf | 08/30/2023 |
| BillText | https://www.congress.gov/118/bills/hr3884/BILLS-118hr3884ih.pdf | 07/05/2023 |
Loading...